<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="nkrs-torontotierIImanualstaging"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p>This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-torontotierIImanualstaging defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">M0<a name="nkrs-torontotierIImanualstaging-M0"> </a></td><td>M0</td><td>No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumour cells in the cerebrospinal fluid (CSF)</td></tr><tr><td style="white-space:nowrap">M1<a name="nkrs-torontotierIImanualstaging-M1"> </a></td><td>M1</td><td>Tumour cells in the CSF</td></tr><tr><td style="white-space:nowrap">M2<a name="nkrs-torontotierIImanualstaging-M2"> </a></td><td>M2</td><td>Visible metastasis in brain</td></tr><tr><td style="white-space:nowrap">M3<a name="nkrs-torontotierIImanualstaging-M3"> </a></td><td>M3</td><td>Visible metastasis in spine or visible metastasis in cervicomedullary (junction)</td></tr><tr><td style="white-space:nowrap">M4<a name="nkrs-torontotierIImanualstaging-M4"> </a></td><td>M4</td><td>Metastasis outside of the central nervous system</td></tr><tr><td style="white-space:nowrap">Localised<a name="nkrs-torontotierIImanualstaging-Localised"> </a></td><td>Localised</td><td>Used for Ewing’s sarcoma or osteosarcoma : tumour confined to the area of origin including regional lymph nodes Although more detailed staging systems exist their clinical and prognostic value is limited, multi-tiered staging systems were not deemed appropriate</td></tr><tr><td style="white-space:nowrap">Metastatic<a name="nkrs-torontotierIImanualstaging-Metastatic"> </a></td><td>Metastatic</td><td>Used for Ewing’s sarcoma or osteosarcoma with distant metastases present at diagnosis. Although more detailed staging systems exist their clinical and prognostic value is limited, multi-tiered staging systems were not deemed appropriate</td></tr></table></div>
  </text>
  <url value="http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-torontotierIImanualstaging"/>
  <version value="0.9.0"/>
  <name value="NkrsTorontoTierIIManualStaging"/>
  <title value="NKRS - Toronto Tier II (Manual) Staging"/>
  <status value="active"/>
  <date value="2022-02-04T14:14:21+01:00"/>
  <publisher value="Bundesamt für Gesundheit BAG"/>
  <contact>
    <name value="Bundesamt für Gesundheit BAG"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.bag.admin.ch/"/>
    </telecom>
  </contact>
  <description value="The Toronto Paediatric Cancer Stage Guidelines recommend the malignancy-specific staging system most suitable &#xD;&#xA;for use by population registries for 16 of the most common childhood malignancies. The Guidelines include a two-tiered &#xD;&#xA;approach that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) &#xD;&#xA;based on collapsing of the more detailed criteria (Tier 2). &#xD;&#xA;&#xD;&#xA;**Toronto Tier II (manual) staging (Variable number: 4.33.2)** &#xD;&#xA;in \&#39;NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)\&#39;&#xD;&#xA;([EN](https://www.nacr.ch/assets/files/uploads/a-datadictionary-basicvariables-v1.1.pdf), &#xD;&#xA;[DE](https://www.nkrs.ch/assets/files/uploads/a-datenstruktur-variablen-der-basisdaten-v1.1.pdf), &#xD;&#xA;[FR](https://www.onec.ch/assets/files/uploads/a-dict-des-donnees-variables-de-base-v1.1.pdf), &#xD;&#xA;[IT](https://www.snrt.ch/assets/files/uploads/a-dati-oncologici-variabili-di-base-v1.1.pdf))"/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="CH"/>
    </coding>
  </jurisdiction>
  <copyright value="CC-BY-SA-4.0"/>
  <caseSensitive value="true"/>
  <valueSet value="http://fhir.ch/ig/ch-crl/ValueSet/nkrs-torontotierIImanualstaging"/>
  <content value="complete"/>
  <count value="7"/>
  <concept>
    <code value="M0"/>
    <display value="M0"/>
    <definition value="No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumour cells in the cerebrospinal fluid (CSF)"/>
  </concept>
  <concept>
    <code value="M1"/>
    <display value="M1"/>
    <definition value="Tumour cells in the CSF"/>
  </concept>
  <concept>
    <code value="M2"/>
    <display value="M2"/>
    <definition value="Visible metastasis in brain"/>
  </concept>
  <concept>
    <code value="M3"/>
    <display value="M3"/>
    <definition value="Visible metastasis in spine or visible metastasis in cervicomedullary (junction)"/>
  </concept>
  <concept>
    <code value="M4"/>
    <display value="M4"/>
    <definition value="Metastasis outside of the central nervous system"/>
  </concept>
  <concept>
    <code value="Localised"/>
    <display value="Localised"/>
    <definition value="Used for Ewing’s sarcoma or osteosarcoma : tumour confined to the area of origin including regional lymph nodes Although more detailed staging systems exist their clinical and prognostic value is limited, multi-tiered staging systems were not deemed appropriate"/>
  </concept>
  <concept>
    <code value="Metastatic"/>
    <display value="Metastatic"/>
    <definition value="Used for Ewing’s sarcoma or osteosarcoma with distant metastases present at diagnosis. Although more detailed staging systems exist their clinical and prognostic value is limited, multi-tiered staging systems were not deemed appropriate"/>
  </concept>
</CodeSystem>